Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects

Nonsteroidal anti-inflammatory drugs, including acetylsalicylic acid, can have a dose-dependent nephrotoxic effect. The study of the pharmacokinetics of acetylsalicylic acid products will contribute to timely detection and correction of side effects caused by this medicinal product.The aim of the study was to evaluate potential nephrotoxic effects following a single oral administration of 75 mg of acetylsalicylic acid, based on the analysis of the pharmacokinetic parameters.Materials and methods: the study involved 24 healthy volunteers who received 75 mg of acetylsalicylic acid (tablets) once orally. The measurement of the active metabolite of acetylsalicylic acid—salicylic acid—in blood plasma was performed by HPLC/MS using an Agilent 1200 liquid chromatography system coupled to an Agilent 6140 tandem mass spectrometer. Agilent Eclipse XDB-C18 column (4.6 mm×150 mm; 5.0 μm) was used for chromatographic separation. The test procedure used in the study was validated. The results obtained were used to calculate the pharmacokinetic parameters: Cmax (maximum concentration), Tmax (time to maximum concentration), T1/2 (half-life of the drug), AUC0-t (area under the pharmacokinetic curve from 0 to the last time point of the curve), AUC0-∞ (total area under the pharmacokinetic curve from 0 to ∞), MRT (mean residence time of the drug in the blood), Kel (elimination rate constant), Cl/F (total clearance), Vd/F (apparent volume of distribution). The Statistics (22.0.0.0) software was used for statistical processing of the results.Results: T1/2 of salicylic acid in blood plasma was determined to be 1.6 ± 0.5 h, Cmax was 4523.0 ± 725.0 ng/mL, and Tmax was 0.98 ± 0.4 h. AUC0–t was equal to 16183.0 ± 3823.0 ng×h/m, Vd/F was 12.0 ± 3.1 L/kg, and MRT was 2.9 ± 0.6 h.Conclusions: the analysis of the pharmacokinetic parameters demonstrated a high absorption rate, intensive distribution, and moderate elimination rate of salicylic acid (the main metabolite of acetylsalicylic acid), indicating a low risk of nephrotoxic effects associated with the studied dose of the drug

Numerical Simulation of the Medical Linear Accelerator Electron Beams Absorption by ABS-Plastic doped with Metal

In this paper the numerical simulation results of the dose spatial distribution of the medical electron beams in ABS-plastic doped with different concentrations of lead and zinc are shown. The dependences of the test material density on the lead and zinc mass concentrations are illustrated. The depth dose distributions of the medical electron beams in the modified ABS-plastic for three energies 6 MeV, 12 MeV and 20 MeV are tested. The electron beam shapes in the transverse plane in ABS-plastic doped with different concentrations of lead and zinc are presented

Значение редокс-статуса коэнзима Q10 как биомаркера окислительного стресса

The article examines the role of ubiquinone as a redox molecule whose functions consist in electron transport in the mitochondrial respiratory chain and regeneration of endogenous antioxidants. Changes in electron redox pathways cause uncontrolled release of reactive oxygen species, which leads to oxidative stress and development of pathologies. The objective of the study was to determine the content of coenzyme Q10 and its redox status in the human body as a biomarker of oxidative stress in various pathologies. This was achieved by assessing and consolidating data on changes in concentrations of the oxidized, reduced ubiquinone forms and total ubiquinone in various pathologies. Total serum ubiquinone was reduced in patients with chronic heart failure (0.68 μmol/L) compared with the control group (0.97 μmol/L). The redox status, expressed as the [ubiquinol]/ [ubiquinone] concentration ratio, decreased in patients with coronary heart disease (0.49 ± 0.34), diabetes (0.26 ± 0.16) compared with the healthy subjects (1.23–1.41). A negative correlation with malonic dialdehyde was observed. The authors analysed the possibility of assessing the efficacy of statin therapy by plasma ubiquinone concentration in patients. Patients with hyperlipidemia who received statins showed a statistically significant reduction in ubiquinol concentration after taking the drug (from 0.81 to 0.46 μg/mL) and the [ubiquinone]/[total ubiquinone] ratio (from 11 to 10 %), which confirms the potential mechanism of statinassociated muscle injury development. Thus, coenzyme Q10 redox status, as well as the concentrations of oxidized, reduced and total ubiquinone can be effective biomarkers of oxidative stress in cardiovascular diseases, diabetes, as well as an important indicator in evaluating the efficacy of hyperlipidemia treatment.Рассмотрена роль убихинона как редокс-молекулы, функциями которой являются перенос электронов в дыхательной цепи митохондрии и регенерация эндогенных антиоксидантов. Изменение редокс-путей электронов вызывает неконтролируемую выработку активных форм кислорода, что приводит к окислительному стрессу и развитию патологий. Цель работы — выявление содержания коэнзима Q10 и значения его редокс-статуса в организме как биомаркера окислительного стресса при различных патологиях, для чего были оценены и обобщены данные о динамике концентраций окисленной, восстановленной формы и общего убихинона при различных патологиях. Содержание общего убихинона в сыворотке крови пациентов с хронической сердечной недостаточностью было снижено (0,68 мкмоль/л) по сравнению с контрольной группой (0,97 мкмоль/л). Редокс-статус, выраженный как отношение концентрации [убихинол]/[убихинон], снижался у пациентов с ишемической болезнью сердца (0,49 ± 0,34), диабетом (0,26 ± 0,16) по сравнению со здоровыми лицами (1,23–1,41). При этом наблюдалась отрицательная корреляция с малоновым диальдегидом. Проведен анализ возможности оценки эффективности статинотерапии по содержанию убихинона в плазме крови пациентов. У пациентов с гиперлипидемией, получавших статины, были достоверно снижены концентрация убихинола после приема препарата (с 0,81 до 0,46 мкг/мл) и соотношение [убихинон]/[общий убихинон] (с 11 до 10 %), что подтверждает потенциальный механизм возникновения статин-ассоциированных поражений мышц. Таким образом, редокс-статус коэнзима Q10, а также концентрация окисленного, восстановленного и общего убихинона могут быть эффективными биомаркерами окислительного стресса при сердечно-сосудистых заболеваниях, диабете, а также важным показателем при оценке эффективности лечения гиперлипидемии

Derivation of a Myeloid Cell-Binding Adenovirus for Gene Therapy of Inflammation

The gene therapy field is currently limited by the lack of vehicles that permit efficient gene delivery to specific cell or tissue subsets. Native viral vector tropisms offer a powerful platform for transgene delivery but remain nonspecific, requiring elevated viral doses to achieve efficacy. In order to improve upon these strategies, our group has focused on genetically engineering targeting domains into viral capsid proteins, particularly those based on adenovirus serotype 5 (Ad5). Our primary strategy is based on deletion of the fiber knob domain, to eliminate broad tissue specificity through the human coxsackie-and-adenovirus receptor (hCAR), with seamless incorporation of ligands to re-direct Ad tropism to cell types that express the cognate receptors. Previously, our group and others have demonstrated successful implementation of this strategy in order to specifically target Ad to a number of surface molecules expressed on immortalized cell lines. Here, we utilized phage biopanning to identify a myeloid cell-binding peptide (MBP), with the sequence WTLDRGY, and demonstrated that MBP can be successfully incorporated into a knob-deleted Ad5. The resulting virus, Ad.MBP, results in specific binding to primary myeloid cell types, as well as significantly higher transduction of these target populations ex vivo, compared to unmodified Ad5. These data are the first step in demonstrating Ad targeting to cell types associated with inflammatory disease

РАЗРАБОТКА ТЕХНОЛОГИИ ПОЛУЧЕНИЯ ПЛАСТИФИКАТОРОВ НА ОСНОВЕ ТРИМЕТИЛОЛПРОПАНА

Polyhydric alcohols - neopolyols and their derivatives due to the nature of the structure have a row of unique properties - high thermal stability, moisture resistance, chemical resistance and are widely used in the production of synthetic oils, resins, varnishes, surfactants and plasticizers. Esters of neopolyols with several ester groups have excellent characteristics at low temperatures, as well as high environmental friendliness, which meets modern requirements. The variation in the production of esters of neopolyols, alcohol and acid components in various combinations allows to obtain a wide range of products with different characteristics and consumer properties. Currently, neopolyol esters are not produced in Russia. However, the technical capabilities of the development of R-Oxo technology based on natural gas are not in doubt, which will allow in the near future to organize its own production of neopolyol esters for the production of high-tech materials. In the present work, the possibility of obtaining plasticizers based on trimethylolpropane esters and C2-C5 acids of various structures was investigated. Samples of 7 trimethylolpropane triesters were synthesized and their certain physicochemical properties were determined. It is shown that the most promising is the synthesis of a plasticizer using acetic acid. Conducted kinetic studies on the esterification of trimethylolpropane with acetic acid. A differential method was used to estimate the reaction rate from the initial consumption rates of acetic acid. The first orders of reaction are determined by alcohol and catalyst under the conditions studied; the value of the observed activation energy of the obtained reaction of the pseudo-second order, in the temperature range of 80-115 °C, was 57.9±8.1 kJ/mol. The results obtained allow us to recommend the conditions for the implementation of the process in the industry.Многоатомные спирты - неополиолы и их производные - в силу особенностей структуры обладают рядом уникальных свойств: высокой термостабильностью, влагоустойчивостью, химической стойкостью и находят широкое применение в производстве синтетических масел, смол, лаков, поверхностно-активных веществ и пластификаторов. Сложные эфиры неополиолов с несколькими сложноэфирными группами обладают прекрасными характеристиками при низких температурах, а также высокой экологичностью, что отвечает современным требованиям. Варьирование при производстве эфиров неополиолов спиртового и кислотного компонентов в различном сочетании позволяет получить широкий спектр продуктов с различными характеристиками и потребительскими свойствами. В настоящее время сложные эфиры неополиолов в России не производятся. Однако технические возможности освоения технологии R-Oxo на базе природного газа не вызывают сомнений, что позволит в ближайшее время организовать собственное производство сложных эфиров неополиолов для производства высокотехнологичных материалов. В представленной работе исследована возможность получения пластификаторов на основе сложных эфиров триметилолпропана и кислот С2-С5 различного строения. Синтезированы образцы 7 триэфиров триметилолпропана и определены их некоторые физико-химические свойства. Показано, что наиболее перспективным является синтез пластификатора с использованием уксусной кислоты. Проведены кинетические исследования по этерификации уксусной кислоты триметилолпропаном. Использовали дифференциальный метод оценки скорости реакции по начальным скоростям расходования уксусной кислоты. Определены первые порядки реакции по спирту и катализатору в изученных условиях; значение наблюдаемой энергии активации изученной реакции псевдовторого порядка в температурном интервале 80-115 °С составило 57.9±8.1 кДж/моль. Полученные результаты позволяют рекомендовать условия для реализации процесса в промышленности

The Physics of the B Factories

This work is on the Physics of the B Factories. Part A of this book contains a brief description of the SLAC and KEK B Factories as well as their detectors, BaBar and Belle, and data taking related issues. Part B discusses tools and methods used by the experiments in order to obtain results. The results themselves can be found in Part C

THE MODERN METHODS OF ANALYSIS OF OXIDIZED AND REDUCED FORMS OF COENZYME Q₁₀ IN BIOMATERIAL (REVIEW)

In the human body, coenzyme Q10 is in the oxidized and reduced forms and can be found in every organ. The review describes modern HPLC methods of coenzyme Q10 analysis using electrochemical, spectrophotometric and mass spectrometric detectors. In the article we present information on sampling, preparation of biomaterial for analysis and preservation of coenzyme Q10 stability in biomaterial. It is carried out a comparative analysis of the determination methodologies for the oxidized and reduced forms of coenzyme Q10 by its sensitivity and selectivity